Skip to main content
Skip to navigation

Featured Profile: Patrick Delafontaine

Patrick Delafontaine

Dean Patrice “Patrick” Delafontaine is renowned for his achievements in research and leadership.

Continuously funded by the National Institutes of Health (NIH) for more than 25 years, Delafontaine’s research focuses on cardiovascular disease. Among other topics, he investigates the role of hormones in blood pressure, mechanisms of heart attacks and muscle weakness in chronic congestive heart failure, a condition in which the heart can’t pump enough blood. Delafontaine has published widely on these topics and has been recognized with numerous honors, including the Established Investigator Award from the American Heart Association.

Over his career, Delafontaine has been recognized by his peers as an outstanding leader who builds excellent programs. In 2012, along with researchers at Louisiana State University and the Pennington Biomedical Research Center, he received a five-year $20 million grant from the NIH to create a collaborative research initiative dedicated to biomedical research, including cardiovascular disease.

Delafontaine joined the MU faculty in 2014, following many years of service as Chief of Cardiology at Tulane University in New Orleans. He also has held clinical leadership positions at the University of Kansas Medical Center, the University of Geneva and Emory University in Atlanta. Since 2001, he has been elected annually by his peers for inclusion in Best Doctors in America®.

Dr. Patrick Delafontaine is Hugh E. and Sarah D. Stephenson Dean and Professor of Medicine and of Medical Pharmacology and Physiology in the School of Medicine.

Click here to download a PDF of this story.

Related Initiative(s):
One Health/One Medicine